Files
Download Full Text (7.5 MB)
Contents
- Cellular Studies Guide Scheduling of Ara-C Treatment for Patients with Acute Leukemia
- Potent Noncardiotoxic Drug Proves Effective for Metastatic Breast Cancer
- Factors Affecting Accurate Reading Of CEA Tumor Marker Levels Detailed
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
1983
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Plunkett, William, 1943-; Estey, E. H. (Elihu H.); Keating, Michael J.; Freireich, Emil J., 1927-; Yap, Boh-Seng; Blumenschein, George R.; Barnes, Brian C.; Bodey, Gerald P., 1934-; Esparza, Delores; Norris, Lucy; Verges, Anita; Houston, Gary R.; Fritsche, Herbert A.; Ford, Richard J., 1943-; Fuller, Lillian M., 1923-; Hagemeister, Fredrick B.; Yap, Hwee-Yong; Puckett, William H.; Leukemia; Cytarabine; Breast Neoplasms -- secondary; Neoplasm Metastasis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Anthracenes; Biomarkers, Tumor.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
The University of Texas MD Anderson Cancer Center; Yap, Hwee-Yong MD; Blumenschein, George R. MD; Barnes, Brian C. MD; Schell, Frank C. MD; Bodey, Gerald P. MD; and Fritsche, Herbert A. Jr., PhD, "OncoLog, Volume 28, Number 03, July-September 1983" (1983). OncoLog MD Anderson's Report to Physicians (All issues). 3.
https://openworks.mdanderson.org/oncolog/3
Conditions Governing Access
Open
